Viewing Study NCT01048034

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:34 AM
Ignite Modification Date: 2026-02-04 @ 5:27 AM
Study NCT ID: NCT01048034
Status: COMPLETED
Last Update Posted: 2013-10-29
First Post: 2010-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)
Sponsor: Nordic MDS Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndrome View
None Chronic Myelomonocytic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myelodysplastic syndrome View
None Chronic myelomonocytic leukemia View
None Transfusion therapy View
None Transfusion dependency View
None Hypomethylating therapy View
None Azacitidine View
None DNA-methylation View
None Epigenetic modifications View